Conversely, upregulation of FZD10 has been reported in multiple tumors such as colorectal cancer, gastric cancer, cervical cancer, breast cancer, and synovial sarcoma, whereas the precise outcome of FZD10 in RCC largely remains obscure. Here, FZD10 is linked to renal cell carcinoma.